Abstract
Remote Patient Monitoring (RPM) enables the digital monitoring of chronically ill patients in their home environments and is becoming increasingly important due to the shortage of skilled labour and demographic change. In Germany, RPM is currently primarily reimbursable for heart failure, while the USA is already showing a broader range of applications and greater involvement of pharmacies. Studies have shown positive effects on clinical outcomes and care efficiency. For Germany, the linking of real-world data with billing and clinical data offers the opportunity for a well-founded evaluation of the medical and economic benefits of RPM.